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During a study of the behavior of sera derived from patients
with carcinomait became obvious that with theso-called "carcinolytic
reaction" consistent results were not to be obtained, although accu-
mulating data but added to the conviction that such sera possess
properties which, in their action on cancer cells, distinguish them
from normal sera. Inability so to adjust a carcinoma cell-serum-
complement system that dependable readings based on cell counts
could be obtained led to the application of various other possible
technics in an effort to disclose some method which would make
possible a differential test. Among these trials was that of sedimen-
tation velocity under various conditions, the inference being that if
the carcinoma serum lacked some specific factor present in normal
serum and responsible, with the aid of complement, for lysis of the
cancer cell, contact between this complemented serum and the cancer
cell might well result in a medium with properties differing from
those of a comparable medium derived from normal serum-comple-
ment-cancer cell mixtures, especially if the action of normal serum
is truly lytic. Such a difference might be revealed by the rate at
which erythrocytes, from the cancer patient or from normal blood,
would sediment.
Preliminary tests showed that when the serum of the cancerous
individual was combined with complement and cancer cell suspension
and then used with an equal volume of a 25 per cent suspension of
the homologous red cells, the degree of sedimentation was slightly,
but definitely, less than was the case when the serum and the cells
from a normal person were used under the same conditions.
Throughoutaseriesofsuchtestsaretardation oftheCa-erythrocytest
occurred,-a result somewhat unexpected since the literature repeat-
edly mentions the accelerated rate at which the red cells of patients
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with malignant tumors sediment. Manifestly, the obvious procedure
was to cross the tests,-to allow erythrocytes from the carcinoma
patient tosediment through mixtures, one ofwhich was derived from
the homologous, the other from normal, serum; and to permit red
cells ofthe normal person to settle through a mixture prepared from
Ca-serum as well as through one made with the normal serum itself.
Such tests showed, in the first place, that the red cell of either deriva-
tion did not sediment so fast or so far in the heterologous as in the
homologous serum mixture, but despite a retardation common to
both, the cells from the carcinoma patient fell less rapidly than did
the normal cells. These results seemed to warrant further tests.
The present series consists of titrations made with 153 bloods
from persons with a preliminary diagnosis of cancer of some type,
or in whom such a diagnosis was considered, and with 247 bloods
from patients in whom there was no particular reason to suspect
cancer and hence could be considered normal in this respect. As
will be pointed out later, all of those in the first group did not prove
to show malignancy, and certainly those termed "normal" were, in
fact, far from normal in many cases, although there may have been
in this group no carcinoma patients.
In preparing the fluid medium through which the red cells were
to sediment, mixtures were made as follows:
0.3 cc. of serum (Ca or normal) inactivated at 560 for 15 min.
0.3 cc. of guinea-pig complement (undiluted serum)
0.3 cc. of carcinoma cell suspension
Theserum-complement-cells were allowed to stand at room temper-
ature for 2 hours, when the mixture was centrifuged. To 0.3 cc. of
the supernatant fluid were added 0.3 cc. of a 25 per cent suspension
of washed erythrocytes, and tests for sedimentation were set up.
The erythrocytes and sera tested. Material for the tests, both
the red cells and the sera, were obtained from specimens of blood
submitted to the laboratory for routine Wassermann and Kahn test-
ing. Selection of the bloods for testing, both as Ca specimens and
as normal controls, was madesolely upon the basis of thepreliminary
diagnosis. The reagents were used, as a rule, within 24 hours of
the time of bleeding, the blood being refrigerated in the meantime.
Before use, the serum was inactivated at 560 C. for 15 min., and
in the test was used undiluted in the quantity indicated. The ery-
throcytes were securedbyplacing the dot in a small piece of organdy
in a Petri dish containing normal saline, and by means of a pipette
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attached to a rubber bulb the cells were washed out with gentle
pressure. These were centrifuged and washed three times, the final
material being a 25 per cent suspension made from packed cells.
This percentage was adopted since heavier suspensions failed to give
as clear-cut differences, and lighter ones tended to produce columns
somewhat feathery at the top and more difficult to read. In the
test the final cell suspension becomes 12.5 per cent.
Since in many instances the red cells were to be tested in mix-
tures containing sera other than the homologous one, it was essential
to make all cross-tests within the blood group, in so far as the A - B
antigens were concerned. Incidentally, it may be mentioned that
there is some evidence that cells of the different blood groups may
fall at slightly different rates, at least, through a medium of the
type used in these tests. These differences do not, however, repre-
sent constant values.
Complement. Only active guinea-pig complement was used.
Determinations made to ascertain if titer were significant suggested
that the hemolytic unit value of the complement was unimportant,
provided a fair potency remained. Inactivation of the complement
unmistakably modifies its properties and its behavior in the test; in
general, sedimentation of both Ca and normal red cells is retarded
in mixtures containing inactivated complement. In non-comple-
mented mixtures less uniform and less consistent results are obtained.
Titrations of complement, diluted with saline or with inactivated
guinea-pig serum, failed to provide anything which might be re-
garded as a unit. Thus, although guinea-pig serum as active com-
plement appears to be essential, the manner in which it acts is not
clear.
Suspension of carcinoma cells. The cells used in all tests were
prepared from the Twort tumor maintained in mice. The excised
tumor was washed with saline (containing 10 per cent of a saturated
solution of tricresol) by gentle pressure until a fairly heavy suspen-
sion of cells had been expressed through the organdy enclosing the
tissue. These cells were centrifuged and washed twice. After the
final suspension had been allowedto stand for approximately 2 hours
to permit the masses to settle, the middle portion of the column was
removed and used for preparing the mixtures, constituted, as stated
above, of equal parts of this suspension, of the serum under test,
and of complement. After a further 2-hour incubation period and
centrifugation, the supernatant fluid served as the fluid phase in the
sedimentation tests.
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The tests were made in pipettes graduated in hundredths and
specially selected by the manufacturer as to uniformity of bore,-
approximately 1.5 mm. When filled to the zero mark with the test
reagents, with the bottom of each pipette sealed, they were placed
vertically and held at room temperature. Readings were made after
intervals of 1, 2, and 19 hours. Under the conditions of the tests
sedimentation was slow and differences in the early readings were
slight. Consequently, the 19-hour reading was accepted as the
value for comparison. Many attempts were made to modify the
technic in such a way that a maximum difference between the carci-
noma and normal bloods would be obtained. Extending the periods
of incubation, varying the temperature, and adjusting the quantities
used failed to improve upon the procedure here outlined.
It is important to point out the fact that in this series of tests
there is no constant standard for comparison; indeed, all attempts
at devising such a standard, suited to this work, met with little
success. Since the serum of the patient, the complement, the red
cells, and, above all, the Ca-cell suspensions used varied, no direct
comparison of one group of tests with another is possible. The
absolute values are, therefore, without significance and comparison
of readings can only be made within the group where serum and red
cell; are the only variables,-the serum in the initial incubation, the
cells in the test for sedimentation.
Consideration of the datg presented in tabulated form below
shows that the differences in sedimentation rates were not large.
Further, it is evident that the bloods used as controls differ widely
when they are compared with the value obtained on blood from a
patient later shown to have cancer. Unfortunately, no data are
available as to the range with bloods which might fairly be con-
sidered as normal, but it is evident that many of the non-cancerous
bloods were far from normal. While the age of the patients pro-
viding the "normal" bloods is not in all cases given, it may be said
that they were between 20 and 60 years, and that within this range
no difference attributable to an age factor was detected. With neither
the Ca nor the normal bloods did the presence of a positive Wasser-
mann or Kahn reaction appear to be reflected in the sedimentation.
The two cases of pernicious anemia whose bloods happened to be
included in the series show the increase in sedimentation velocity
describedbyotherworkers with simplesedimentation technics. While
no large series of pregnancy bloods was tested, those examined
appeared to behave much as did those of proved cases of cancer.
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The following table embraces the data which serve as the basis for the foregoing discussion.
The sedimentation values for the 153 suspected bloods are given together with the values for the
controls, assumed to be normal bloods. The figures in parentheses represent the + or
differences between the Ca system and the particular controls for that test. In some
instances several control bloods were tested. Where the age of the patient is available it
is given, in parentheses, after the preliminary diagnosis.
,S sdimentation after 19 hrs.; in mm. -5
Preliminary Final Ca-serum -NNormal serum system s->
diagnosis diagnosis system a b c
Casigmoid .................... Casigmoid 36 48(-12) 49(-13)
? Ca stomach ... Ca stomach 48 53(-5) 51(-3)
Caprostate ....-........... 32 41(-9) 46(-14)
Ca stomach ... Ca stomach 36 (-5) (-10)
Ca cervix ... Ca cervix 29 33(-4)
Ca cervix ... Squamous cell Ca 34 31 (+3)
? Ca uterus ... No malignancy 38 36(+2) 36(+2)
Ca esophagus ................ 34 (-2) (-2)
Ca esophagus .......... Cyst 47 46(+1)
Ca mouth ........... - 15 14(+1)
Ca stomach ....... ... Ca or ulcers 59 53(+6)
Sarcoma .. ........ 32 24.5(+7.5)
? Ca breast ....... ... Ca breast 18.5 25(-6.5)
? Ca uterus (42) .......... Ca uterus 17 (-8)
Ca cervix (53) .......... Squamous cell Ca 22.5 30(-7.5)
Ca stomach (56) .......... Ca stomach 14 16(-2)
Ca esophagus ................ 32.5 26(+6.5) 23.5(+9)
Ca tongue .... ...... Ca tongue 24 (-2) (+0.5)
Ca prostate (81) .......... Nomalignancy 46 34(+12)
Ca larynx (42) .......... Squam. cell Ca
pharynx 32.5 36(-3.5) 35 (-2.5)
Ca stomach (55) ...... Ca stomach 25 (-11) (-10)
Ca stomach ... ... Ca stomach 18 21 (-3)
? Ca uterus (44) .......... 19 22.5(-3.5)
Ca larynx (78) ........ Squam. cell Ca
larynx 29.5 25.5(+4)
Ca face (61) .... ... BasalcellCa 24.5 (-1)YALE JOURNAL OF BIOLOGY AND MEDICINE
Preliminary
diagnosis
Ca prostate ...................
Ca breast (46) ..............
Ca colon (66) ................
Ca penis .......................
Ca stomach (73) ..........
Ca prostate (48) ............
Ca rectum (68) ............
Ca pharynx (53) ..........
Ca colon (63) ................
Ca colon (62) ................
Ca mouth (70) ..............
Ca cervix (72) ..............
? Ca stomach (39).
Ca prostate (69) ............
Ca stomach (67) ..........
Ca sigmoid&rectum (67)
Ca uterus (56) ..............
? Ca (58) ......................
Ca stomach ................
Ca cervix (72) ..............
Ca larynx (59) ..............
Ca ear (70) ..................
? Ca uterus (64) ..........
Ca cervix (27) ..............
Ca colon (70) ..............
Ca stomach (51) ............
Ca cervix (33) .............
Ca kidney (62) ............
Ca stomach (75) ............
Final Ca
diagnosis j
Ca prostate
Ca breast
Ca colon
Ca penis
Ca prostate
Ca rectum
Ca colon
Ca colon
Ca mouth
Ca cervix
Ulcer
Nomalignancy
Ca stomach
Ca sig. & rect.
Metastatic malig.
Ca stomach
Ca cervix
No malignancy
Squamous Cell Ca
No malignancy
-serum
system
24.5
16.2
20
18
15.5
21
19
15.5
16
16
18.5
19.5
24
24
13.5
15.5
30.5
18
22
24
23
25
21
21
15
17
18
15.5
16.5
Wedimentation after 19 hrs.; in mm. -5
Normalserum systms -
a b c
25.5 (-1)
20(-3.8) 18.5(-2.3)
27(-7) 31(-11)
21(-3) 21.5(-3.5)
20(-4.5)
22(-1) 22.5(-1.5)
19.5(-0.5) 21(-2)
17(-1.5) 16(-0.5)
20(-4) 18(-2)
18(-2) 18.5(-2.5)
(+0.5) (0)
22.5(-3) 20(-0.5) 20(-0.5)
25.5(-1.5) 24.5(-0.5)
(-1.5) (-0.5)
16(-2.5)
(-0.5)
32.5 (-2) 30((+0.5)
23.5 (-5.5) 22.5(-4.5)
26(-4)
30(-6)
26(-3) 26(-3) 25(-2)
27(-2)
20(+1)
19.5((+1.5) 21.5(-0.5)
20(-5) 18.2(-3.2) 21(-6)
15.5(+1.5) 19(-2)
17.5((+0.5) 16.5(+1.5) 19(-1)
(-2) (-1) (-3.5)
(-1) (0) (-2.5)
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,-Se imentation after 19 hrs.; in mm. ->
Preliminary Final Ca-serum - Normal serumm
diagnosis diagnosis system a b c
? GI malignancy (54).... 14.2 18.7(-4.5) 17.2(-3)
? Ca (63) ........... Arthritis 15.5 (-3.2) (-1.8)
Ca bladder (72) ........... Ca bladder 15 16(-1) 15.2(-0.2)
? Ca stomach (58) ......... Nomalignancy 15 15.5(-0.5) 16(-0.;) 15.5(-0.5)
15(0)
Sarcoma eye (52) .......... No sarcoma
(Wass.+) 22.5 22(+0.5) 16.5 (+6)
Ca prostate (62) ............ Ca prostate 22.5 (+0.5) (+6)
Ca stomach (64) .......... No malignancy 22 (0) (+5.5)
Carectum (59) ............ Carectum 23.5 24.5(-1) 25.5(-2) 21.7(+1.5)
28(-4.5) 27.5 (-4) 27.5(-4)
Ca bladder (75) ............ Ca bladder 26.5 (+2) (+1) (+4.8)
( 1-5) (-0) (-0)
Sarcoma eye (40) .......... Nosarcoma 27 23(+4) 22.5(+4.5) 26(+1)
23.5(+3.5)
Ca bladder ................ 20 25.5(-5.5) 22.5(-2.5) 22.5(-2.5)
21.2(-1.2) 23.5(-3.5) 21.5(-t.5)
> Cacolon (47) ............ Hernia 23.7 25(-1.3) 25.5(-1.8) 22.5(+1.2)
Tumor breast (59) ........ ? Malignancy 22 23.5(-1.5)
Tumor breast ........... Chron. cyst. mast. 24 22(+2) 22(+2)
? Castomach (64) 26 31(-5) 31.5(-5.5) 28(-2)
Tumorabdomen (68) .... ? Malignancy 32 28(+4) 25(+7) 26.5(+5.5)
Ca, metastases (75) ........ Ca metastases 21.2 22.2(-1) 22.2(-I) 24(-2.8)
? myomauterus (47) .... Nomalignancy 23 34*(-11) 20.5(+2.5) 20.5(+2.5)
Ca breast ................ No malignancy 22 21.5(+0.5) 21.5 (+0.5) 24(-2)
Ca breast ................ Nomalignancy 26.5 25(+1.5)
Tumor breast ....... No malignancy 29 27(+2)
Lung tumor .... ... Chron. inflam.
bronchus 21 27(-6) 27.5(-6.5) 20.5(+0.5)
Cacolon (50) 17 22.5(-5.5) 21(-4)
Fibroid (41) ................ Nomalignancy 23 (+0.5) (+2)
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, - Sedimentationafter 19 hrs.; in mm. -5
Preliminary Fina Ca-serum -N Normalserumsystem
diagnosis diagnosis system a b c
? Calung (71) .............. 18.5 19(-0.5) 23(-4.5)
Capharynx (65) .......... 21.5 21(+0.5) 22.5(-1) 20(+1.5)
Lipoma; sec. anemia ? (Wass. +;
Kahn +) 25.5 24(+1.5) 23(+2.5) 29(-3.5)
Ca breast (70) .............. Ca breast 22 24(-2) 23(-I)
Benign tumor breast(36) 22.5 (-1.5) (-0.5)
Cabronchus (71) .......... 17 20.5(-3.5) 22.5(-5.5) 20.5(-3.5)
Cerebral neoplasm (40).. No tumor found 17.5 17(+0.5) 18(-0.5)
Sarcoma knee (71) ........ Nosarcoma 18 (+1) (0)
Fibroid uterus (40) ...... Nomalignancy 15.5 17.2(-1.7) 18.5(-3) 17(-1.5)
? Ca prostate (61) ........ Nomalignancy 31.5 31(+0.5) 30(+1.5) 30(+1.5)
30(+1.5)
Ca (64) .................. 26 34(-8) 38(-12) 31(-5)
29(-3)
? Ca (40) ................ Contractionfingers 26 28(-2) 28(-2) 30(-4)
Tumorbreast (29) ........ Notumorfound 27 27(0) 28(-1) 23(+4)
Epithelioma nose (76) .. Epithelioma 26 (-1) (-2) (+3)
Ca bladder ................ Mult. papillomata 17.5 22(-4.5) 19.5(-2) 22(-4.5)
? Ca (58) .. .. Cardiac enlarge-
ment 17 19.5(-2.5) 21(-4) 20(-3)
18.5 (-1.5)
Adenoma breast (19) .... 19.5 (0) (-1.5) (-0.5)
(+1)
? Caliver (79) ............... 20 22(-2) 22.5(-2.5)
Ca nose (71) ................ 22.5 20.5(+2) 21.5(+3) 23(-0.5)
Ca breast (62) .............. Ca breast 28.5 31(-2.5) 30(-1.5)
Epithelioma eyelid (39) Epithelioma 35 (+4) (+5)
Intestinal obstr. (51)...... Intestinal obstr. 19.5 26*(-6.5) 19(+0.5) 20(-0.5)
23(-3.5)
Adenoma prostate (70) .. Chron. prostatitis 19.5 23(-3.5)
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r--- ea imentation after 19 hrs.; in mm. -I
Preliminary Final Ca-serum - Normalserum systems-
diagnosis diagnosis system a b c
Aberrantbreasttissue (49) No malignancy 19.5 19(+0.5) 22.5(-3) 21.7(-2.2)
21.5(-2)
Ca bladder (50) ............ 19 (0) (-3.5) (-2.7)
(-2.5)
? Brain tumor ................ Notumor 22 28(-6) 27(-5) 27(-5)
Fibroid uterus (47) ...... No malignancy 27 (-1) (0) (0)
Peptic ulcer (45) .......... Peptic ulcer 22 27(-5) 25.5(-3.5)
Ca stomach ................ Castomach&esoph. 17 19(-2) 22(-5) 20(-3)
Ca face (62) ................ Squamous cell Ca 17 (-2) (-5) (-3)
Brain tumor 28 28(0)
Ca stomach (63) ......... Ca stomach 24 (-4)
? Ca (53) ............... 31.5 34.5(-3)
Basal cell Ca eyelid (84) Ca eyelid 31.5 25.5 (+6) 26.5 (+7)
Ca cervix (62) ...............SquamouscellCa 31 32(0) 32(0) 28(+4)
Ca prostate (56) ............ Ca with metastasis 25 24(+1)
? Brain tumor (50) 25 36(-11) 28(-3) 25.5(-0.5)
Ca stomach (68) .......... Ca stomach 23 25.5(-2.5) 28.5(-5.5)
? Early Caor ulcer (63) 27 22(+5) 18(+9) 20(+7)
? Ca face (87) .............. ? Squam. cell Ca 26 (+4) (+8) (+6)
? Abdominal malig. (68) 27 (+5) (+9) (+7)
Ca stomach (68) ............ Ca stomach 23 (+1) (+5) (+3)
Ca bronchus (48) .......... Cabronchus 19.5 (-2.5) (+1.5) (+0.5)
Basal cell Ca face (58) .. BasalcellCa 38 36(+2) 32(+6)
Ca rectum (63) ............ Ca rectum 31 (-5) (-1)
Caface(56) 38 (+2) (+6)
Tumor lip (47) 23 25(-2) 28(-5) 27(-4)
Ca cervix (36) .24 (1) (-4) (-3)
? Fibroid (34) .............. Myoma uterus 2! (-4) (-7) (-6)
Castomach (64) .......... Castomach 31.5 34(-2.5) 33(-1.5) 33(-1.5)
Ca esophagus (64) ........ Ca esophagus 34 30(+4) 31(+3)
? Ca larynx (51) ......... No malignancy 34 34(0)
Tumor breast (62) ...... Ca breast 26 26(0) 29(-3)YALE JOURNAL OF BIOLOGY AND MEDICINE
Preliminary
diagnosis
? Ca rectum (60) ..........
Tumor breast (53).
Ca stomach (51) ............
Ca breast (75) ..............
Ca prostate (70) ............
Ca breast (47) ..............
? Ca (64) ....................
Ca colon (57) ..............
Ca colon ........................
Ca pelvis ........................
Ca rectum (63) ............
Ca stomach (70) ..........
Ca rectum (35) ............
Ca pelvis ......................
? Ca uterus (44) ..........
Ca colon (39) ..............
Ca colon (50) ................
Ca esophagus (73)
Ca spleen (64) ..............
Tumor ..........................
Ca mouth (83) ............
Ca breast (74) ..............
C.
C.
C~
C;
N
C
C
C
C
C
II
C
Final Ca-serum
diagnosis system
27
a 28.5
28
a with metastasis 26
a prostate 27
o malignancy 28
30
27
a colon 26
a rectum 16.5
a rectum 24
'a stomach 20.5
23
,a rectum 19
27.5
ioperable Ca 29
31
31
26
30
32.5
la breast 23.5
Sedimentation after 19 hrs.; in mm. -1
eNormal serum systems-
-
a b c
31(-4) 31(-4) 29.5(-2.5)
(-2.5) (-2.5) (-1)
30(-2) 26.5(+1.5)
30(-4) 29.5 (-3.5) 31 (-5)
(-3) (-2.5) (-4)
22.5 (+5.5)
30(0) 30(0) 30(0)
(-3) (-3) (-3)
27(-1)
24.5 (-8) 25.5 (-9)
20(+4) 26(-2)
27(-6.5)
27.5 (-4.5) 22.5 (+0.5)
(-8.5) (-3.5)
30.5 (-3) 29.5 (-2)
33(-4) 29.5(-0.5)
32(-1) 28(+3)
(-1) (+3)
26(0) 26(0)
33(-3) 31(-1)
(-0.5) (+1.5)
27(-3.5)
Despite the difficulty in evaluating the results and the uncertain-
ties due to lack of known and uniform normal controls, it would
seem that a retarded sedimentation occurred more consistently in
those cases diagnosed as cancer. Nevertheless, exceptions to this
rule are sufficient to impose extreme caution in drawing condusions.
Perhaps the most satisfactory results were obtained in those groups
diagnosed as cancers of the stomach, prostate, cervix, colon, bladder,
and breast. Obviously, the test in this form is not adequate for
clinical purposes; it may, however, offer possibilities.
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Another phase of the problem worthy of study is the nature of
the reaction that takes place in the serum-complement-cell mixture,
for, after all, that is the point at which differentiation between the
cancer and the normal serum should be made. The use of erythro-
cytes as an indicator of the nature or extent of this reaction is unsat-
isfactory. This is clearwhen it is recalled that the cancer erythrocyte
sediments more slowly through the supernatant from a normal
serum-complement-Ca cell mixture than do the homologous normal
cells. This suggests that the difference is in some way bound up
with the red cell itself rather than with the serum, but the fact
ERYTHROCYTE SEDIMENTATION: CROSS-TESTS
Cacells Ca. cells Norm. cells Norm. cells
x x x x
Diagnosis Caserum Norm. serum Norm. serum Ca serum
Caesophagus ....................... 34 34.5 37 37
Cacervix ............. ...... 29 29 33 33
Ca cervix ............. ...... 22 22 30 31
Cacervix .... 34.5 37.5 43 41
Calarynx ............. ...... 32.5 30 36 39
Ca stomach ................... 25 25 35 33.5
Castomach ................... 18 18 21 23.5
? Ca uterus ................... 19 19 22.5 19
Capharynx ................... 21.5 22 22.5 24.5
Calung .............. 17 18.5 20.5 24.5
Ca bladder ................... 17.5 20.5 19.5 23
? Caliver ................... 20 21.5 22 25.5
Ca stomach ................... 17 24 22 28
Ca face ........... ........ 17 23 22 30
Ca stomach ................... 24 20 28 29
? Brain tumor ................... 25 24 36 27
Ca stomach ................... 23 20 26.5 25
Ca rectum ................... 31 26 36 27
Ca cervix ............. ...... 25 18 26 23
Ca breast ............. ...... 26 23 31 25
Ca prostate ................... 27 21 31 23
Ca colon ........... ........ 27 20 30 21
Ca pelvis ............. ...... 16.5 14 25.5 19.5
Ca colon ............. ...... 27 19 30 20.5
Ca stomach ................... 20.517 26 21
Ca rectum ................... 23 18 26.5 21.5
Ca pelvis ............. ...... 19 14 26 17
Ca breast .............................. 23.5 16 27 19.5YALE JOURNAL OF BIOLOGY AND MEDICINE
remains that if any one of the materials of the system as here out-
lined is omitted the difference does not appear. No differences were
evident in sedimentation through saline, or in any mixture in which
the tumor cells had been left out. Although it is tempting to read
into thesefacts evidenceofsomespecific serologic change,-occurring
with normal serum, lacking with Ca serum,--such may not be the
case. It may be that the materials here used simply provide a
medium through which, forpurely mechanical reasons, sedimentation
most readily takes place, with the Ca-erythrocyte falling more
slowly.
The results of a few such cross-tests are here tabulated; the
figures indicating the extent of sedimentation, in millimeters, of the
two types of erythrocyte, Ca and normal, in mixtures prepared with
their homologous sera.
While the irregularities in these results are sufficiently numerous
to preclude definite condusions, the tendencies shown may be of
significance. There can be no question but what sedimentation of
the red cells from the Ca-blood tends to be either retarded or
reduced, whatever the medium (prepared with Ca or with normal
sera) through which they fall.
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